Intercure Ltd. (INCR)
NASDAQ: INCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
INCR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $42.03M
- EPS (TTM)
- -$0.95
- Dividend yield
- None
- 52-week range
- 3.12 – 7.55
- Day range
- 3.24 – 3.50
- Volume / Avg
- 18.25K / 15.93K
- Beta
- —
- Shares outstanding
- 12.97M
52-week range
INCR stock today
Shares of Intercure (INCR) finished lower on Nov 20 at $3.24, a drop of 7.69% or $0.27 per share, versus the S&P 500's 3.70% decline. At this level, INCR sits near the bottom of its 52-week range of $3.12 to $7.55: 57.1% below the high, set on Dec 17, 2025 and 3.8% above the low. INCR is down 28.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 50.6%.
Intercure has posted a net loss over the last twelve months (EPS of -$0.95), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Intercure
Company profileInterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Alexander Rabinovich
- Headquarters
- Herzliya
- Employees
- 285
- Website
- intercure.co
Intercure peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OSTXOS Therapies Incorporated | 0.803 | -2.12% | $42.00M | vs INCR |
| BMEABiomea Fusion Inc. | 0.5744 | -2.38% | $41.75M | vs INCR |
| CRBPCorbus Pharmaceuticals Holdings Inc. | 2.06 | -15.40% | $42.45M | vs INCR |
| MREOMereo BioPharma Group plc ADR | 0.26 | -5.45% | $41.52M | vs INCR |
| ELTXElicio Therapeutics Inc. | 1.45 | -3.33% | $41.05M | vs INCR |
| SPROSpero Therapeutics Inc. | 0.742 | -10.20% | $43.23M | vs INCR |
| TLPHTalphera Inc. | 0.7852 | +6.25% | $40.80M | vs INCR |
| RLYBRallybio Corporation | 15.47 | -0.32% | $43.32M | vs INCR |
Indexes, lists and sector
Intercure stock FAQ
What is Intercure's stock price today?
INCR last traded at $3.24 as of Nov 20, 4:00 PM EST, down 7.69% on the day. Prices are delayed at least 15 minutes.
Does Intercure pay a dividend?
No. Intercure does not currently pay a regular cash dividend.
Who is Intercure's CEO?
Mr. Alexander Rabinovich is the chief executive officer of Intercure Ltd., which has about 285 employees.
Has INCR ever split its stock?
Yes. The most recent INCR stock split was a 1-for-5 split on Aug 24, 2026.
What is the INCR 52-week high?
The 52-week high for INCR is $7.55 and the 52-week low is $3.12. The stock is currently 57.1% below its high.